Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Premium

Register

Sign In

EUR/USD

1.2288

-0.0056

-0.45%

GBP/USD

1.4003

-0.0079

-0.56%

USD/JPY

107.65

0.2200

0.20%

USD/CHF

0.9750

0.0033

0.34%

EUR/GBP

0.8774

0.0009

0.10%

USD/CAD

1.2765

0.0100

0.79%

NZD/USD

0.7208

-0.0057

-0.78%

EUR/JPY

132.29

-0.3180

-0.24%

EUR/CHF

1.1980

-0.0014

-0.12%

Celldex Therapeutics Inc.

NASDAQ: CLDXHealthcare / Biotechnology / USA
0.70+0.02+2.94%Vol 6 184 7381Y Perf -78.26%
Apr 20th, 2018 16:00
BID0.70 ASK0.70
Open0.69 Previous Close0.68
Pre-Market0.69 After-Trading0.71
 0.01 1.47%  0.01 1.43%
Target Price
7.33 
Analyst Rating
Strong Buy 1.50
Potencial %
947.14 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★     58.51
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)99 
Earnings Rating
Buy
Price Range Ratio 52wk %
1.81 
Earnings Date
8th May 2018

Today's Price Range

0.690.75

 

52wk Range

0.653.41

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-71.54%
3 Months
-74.64%
6 Months
-76.03%
1 Year
-78.26%
3 Years
-97.49%
5 Years
-94.63%
Last Quotes
Name / TickerPriceChg.Chg.%
CLDX0.700.02002.94
AAPL165.72-7.0800-4.10
GOOG1 072.96-14.7400-1.36
MSFT95.00-1.1100-1.15
XOM79.00-0.4200-0.53
WFC52.561.02001.98
JNJ126.66-0.8900-0.70
FB166.28-1.8200-1.08
GE14.540.55003.93
JPM111.47-0.2500-0.22
...

TickerPriceChg.%52 Week High
RF18.894.0820.21
XRX31.543.9937.42
GE14.543.9330.38
HRB27.102.9231.80
ETFC60.482.8061.80
SCHW54.992.4458.11
SIG38.652.1777.94
UAL71.752.1683.04
WFC52.561.9866.31
RE246.991.91277.17
M29.961.8731.04
CTL17.611.6727.61
HON150.571.65165.13
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.10
Current Ratio 5.20
Long Term Debt to Total Capital -
Total Debt to Equity 0.03
Interest Coverage -
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-857.90
EBITDA Margin-816.30
Pre-tax Profit Margin-2 082.50
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.28
PS Ratios 27.06
Price to Cash Flow 8.30
Price to Free Cash Flow -4.60
Cash Flow Per Share -0.78
Price to Tangible Book3.90
Book Value per Share1.68
Enterprise Value (in ths.)170 447
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-43.76
ROE last 12 Months -37.08
Return on Assets (5Y Avg) -31.38
ROA last 12 Months -26.62
Return on Capital (5Y Avg) -43.21
ROC last 12 Months -25.26
Return on invested Capital Q -1.64
Return on invested Capital Y-36.13
Assets Turnover0.00
Receivables Turnover2.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)11 209
Revenue per Share 0.08
Revenue Growth 3 Years 48.58
Revenue Growth 5 Years 7.65
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017-0.23-0.1726.09
Q03 2017-0.24-0.1441.67
Q02 2017-0.25-0.238.00
Q01 2017-0.28-0.280.00
Q04 2016-0.34-0.3011.76
Q03 2016-0.32-0.299.38
Q02 2016-0.33-0.323.03
Q04 2015-0.34-0.332.94
Earnings Per EndEstimateRevision %Trend
3/2018 QR-0.1781.11Positive
6/2018 QR-0.1780.90Positive
12/2018 FY-0.72--
12/2019 FY-0.71--
Next Report Date8th May 2018
Estimated EPS Next Report-0.17
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume6 184 738
Shares Outstanding (in ths.)141 070
Trades Count7 920
Dollar Volume3 909 825
Avg. Volume2 169 472
Avg. Weekly Volume13 238 242
Avg. Monthly Volume4 326 980
Avg. Quarterly Volume2 378 565

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

86%14%

Bearish Bullish

71%29%

Bearish Bullish

75%25%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
2 (40.00 %)
2 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Moderate Buy
1.80
Moderate Buy
1.80

There are no comments yet.

News

x